Your browser doesn't support javascript.
loading
Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery.
Hausenloy, Derek J; Barrabes, Jose A; Bøtker, Hans Erik; Davidson, Sean M; Di Lisa, Fabio; Downey, James; Engstrom, Thomas; Ferdinandy, Péter; Carbrera-Fuentes, Hector A; Heusch, Gerd; Ibanez, Borja; Iliodromitis, Efstathios K; Inserte, Javier; Jennings, Robert; Kalia, Neena; Kharbanda, Rajesh; Lecour, Sandrine; Marber, Michael; Miura, Tetsuji; Ovize, Michel; Perez-Pinzon, Miguel A; Piper, Hans Michael; Przyklenk, Karin; Schmidt, Michael Rahbek; Redington, Andrew; Ruiz-Meana, Marisol; Vilahur, Gemma; Vinten-Johansen, Jakob; Yellon, Derek M; Garcia-Dorado, David.
Afiliação
  • Hausenloy DJ; The Hatter Cardiovascular Institute, University College London, London, UK. derek.hausenloy@duke-nus.edu.sg.
  • Barrabes JA; The National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, UK. derek.hausenloy@duke-nus.edu.sg.
  • Bøtker HE; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, 8 College Road, Singapore, 169857, Singapore. derek.hausenloy@duke-nus.edu.sg.
  • Davidson SM; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore. derek.hausenloy@duke-nus.edu.sg.
  • Di Lisa F; Department of Cardiology, Vall d'Hebron University Hospital and Research Institute, Universitat Autònoma, Barcelona, Spain.
  • Downey J; Department of Cardiology, Aarhus University Hospital Skejby, 8200, Aarhus N, Denmark.
  • Engstrom T; The Hatter Cardiovascular Institute, University College London, London, UK.
  • Ferdinandy P; Department of Biomedical Sciences and CNR Institute of Neurosciences, University of Padova, Padua, Italy.
  • Carbrera-Fuentes HA; Department of Physiology and Cell Biology, College of Medicine, University of South Alabama, Mobile, AL, USA.
  • Heusch G; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Ibanez B; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
  • Iliodromitis EK; Pharmahungary Group, Szeged, Hungary.
  • Inserte J; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, 8 College Road, Singapore, 169857, Singapore.
  • Jennings R; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.
  • Kalia N; Institute for Biochemistry, Medical Faculty Justus-Liebig-University, Giessen, Germany.
  • Kharbanda R; Department of Microbiology, Kazan Federal University, Kazan, Russian Federation.
  • Lecour S; Institute for Pathophysiology, West-German Heart and Vascular Center, University of Essen Medical School, Essen, Germany.
  • Marber M; Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.
  • Miura T; IIS-Fundación Jiménez Díaz Hospital, Madrid, Spain.
  • Ovize M; 2nd University Department of Cardiology, National and Kapodistrian University of Athens, Athens, Greece.
  • Perez-Pinzon MA; Department of Cardiology, Vall d'Hebron University Hospital and Research Institute, Universitat Autònoma, Barcelona, Spain.
  • Piper HM; Duke University, Durham, NC, USA.
  • Przyklenk K; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.
  • Schmidt MR; Oxford Heart Centre, The John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK.
  • Redington A; Department of Medicine, Hatter Institute for Cardiovascular Research in Africa and South African Medical Research Council Inter-University Cape Heart Group, Faculty of Health Sciences, University of Cape Town, Chris Barnard Building, Anzio Road, Observatory, Cape Town, Western Cape, 7925, South Afri
  • Ruiz-Meana M; King's College London BHF Centre, The Rayne Institute, St. Thomas' Hospital, London, UK.
  • Vilahur G; Department of Cardiovascular, Renal, and Metabolic Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Vinten-Johansen J; Explorations Fonctionnelles Cardiovasculaires, Hôpital Louis Pradel, Lyon, France.
  • Yellon DM; UMR 1060 (CarMeN), Université Claude Bernard, Lyon 1, France.
  • Garcia-Dorado D; Cerebral Vascular Disease Research Laboratories, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
Basic Res Cardiol ; 111(6): 70, 2016 11.
Article em En | MEDLINE | ID: mdl-27766474
ABSTRACT
To commemorate the auspicious occasion of the 30th anniversary of IPC, leading pioneers in the field of cardioprotection gathered in Barcelona in May 2016 to review and discuss the history of IPC, its evolution to IPost and RIC, myocardial reperfusion injury as a therapeutic target, and future targets and strategies for cardioprotection. This article provides an overview of the major topics discussed at this special meeting and underscores the huge importance and impact, the discovery of IPC has made in the field of cardiovascular research.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão Miocárdica / Precondicionamento Isquêmico Miocárdico Limite: Animals / Humans Idioma: En Revista: Basic Res Cardiol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão Miocárdica / Precondicionamento Isquêmico Miocárdico Limite: Animals / Humans Idioma: En Revista: Basic Res Cardiol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido